Garenoxacin (BMS284756) is a des-fluoro(6) quinolone antibiotic effective against Gram-positive and Gram-negative bacteria. It is utilized in research for studying antibacterial mechanisms and efficacy in both in vitro susceptibility assays and in vivo infection models.